SUMMARY
The effects of ionising radiation on the chorioretina are more extensive and occur more often with brachytherapy than with teletherapy because of the much higher doses of radiation employed. In order to control choroidal melanoma, some overlap of normal tissue receives uniformly effective doses of radia tion.l This provides an opportunity to study the effects of ionising radiation on the normal peritu moral choroid, although the secondary effects of tumour and its products, and post-radiation tumour necrosis and retinal pigment epithelial (RPE) changes, may influence the radiation changes in the posterior segment.
Fundus fluorescein angiograms (FF As) after brachytherapy for choroidal melanoma show a gradually progressive occlusion of the choroidal vasculature2---6 in the tumour and peri tumoral area. The vascular changes in conjunction with direct toxicity of radiation contribute to tumour destruc tion. 7, 8 Similarly, previous experimental FFA studies in the rabbit eye have shown choroidal vaso-occlusion after beta-irradiation with ruthenium-l06/rhodium-106 (106RuP06Rh). The onset of the choroidal non perfusion was dose dependent, occurring earlier with higher doses of radiation. Whilst choroidal atrophy occurred in some areas, some of the residual choroidal vasculature was stained with fluorescein dye.9 However, FF A visualisation of the choroid clinically and experimentally is not ideal and is only optimum where RPE and choriocapillaris atrophy are significant.
Indocyanine green angiography (ICG-A), which permits better visualisation of the choroidal vascu lature in vivo (compared with FFA), has recently been introduced into clinical use. I O,ll It allows visualisation of the choroidal vasculature even in the presence of moderate lens opacities. The purpose of this study is to describe the ICG-A changes of radiation choroidopathy and to relate them to the natural course of the disease.
We reviewed the ICG-A changes in the choroidal vasculature in the irradiated ('normal') peri-tumoral zone in 16 patients between 4 to 72 months following 106Ru/106Rh brachytherapy for choroidal melanoma.
MATERIALS AND METHODS
Patients included in this study had choroidal melanoma treated conservatively with local irradia tion from 106Ru/106Rh sources in our clinic. The plaques used are similar to those described by Lommatzsch3,6 and deliver a dose of 100 Gy to the tumour apex (800-1000 Gy to tumour base/sclera). 12 All patients had funduscopy, fundus photography, In an initial period between April 1986 and September 1988, a Topcon TRC 50VT fundus camera equipped with a continuous power light source from a 300 watt halogen bulb and an infrared sensitive camera connected to a video recorder were used. In the second period from July 1992 to December 1993, a Topcon Imagenet Digital Ima ging System linked to a Topcon 50IA camera specially designed for ICG-A and FF A 13 was available for the study.
For the ICG-A procedure, 25 mg ICG was dissolved in 1 ml aqueous solvent and injected into the antecubital vein followed by a 5 ml aqueous solvent flush through a three-way tap. In addition, during the second period of the study, images were architecture of the choroidal microcirculation, capil lary incompetence and closure. The larger choroidal vessels seemed more resistant to radiation injury than the choriocapillaries and smaller choroidal arterioles and venules. Single enlarged choroidal vessels became visible with time and their walls stained with ICG dye.
Similar angiographic changes were observed with FFA, but were less obvious in the absence of significant RPE atrophy. The choriocapillary filling with FF A was more visible in the early angiographic phases in some patients when compared with ICG visualisation.
From 4 to 6 Months
The earliest ICG-A changes observed were peritu moral atrophy of RPE and irregular closure of choriocapillaries and some smaller arterioles and venules (Fig. 1) . Most of the larger choroidal vessels remained perfused at this stage. Occasionally, the large choroidal vessels showed slight dilatation. There was no evidence of ICG dye staining of choroidal vascular walls in the peri tumoral area.
From 10 to 24 Months
The irregular choroidal vascular occlusion, especially of the small-calibre vessels, was now more noticeable in the normal peri tumoral choroid than it had been at 4-6 months (Fig. 2) . The residual vessels were of irregular calibre and showed minimal localised dye staining of their walls.
From 30 to 72 Months
ICG-A confirmed the atrophic changes seen on FFA in the non-tumour treated chorioretina. Only the larger choroidal vessels persisted, with remarkable calibre variation of beading and telangiectatic-like dilatations (Figs. 3-6 ). There was significant beading, especially of the larger arterioles. Focal outpouchings similar to microaneurysms observed in the retinal vasculature were observed. Some of these vessels, including the micro aneurysms, leaked dye locally. Residual vessels showed dilatation at the edge of ischaemic zones (Fig. 3) . There was progressive staining of the larger choroidal vessels: 'perivasculitis' (Figs. 3-6 ). This was associated with progressive closure of the lumen of these vessels. Such vascular staining was not observed earlier than 2 years following radiation treatment, and was very marked in all eyes examined (>2 years).
Vascular anastomoses, which were presumed choroido-choroidal, were detected at the edges of some of the atrophic scars (Fig. 4) . In some eyes, new clusters of abnormal choroidal vessels were observed more than 2 years following treatment. In one case, focal choroidal new vessels were observed with ICG ( Fig. 6 ) outside the original tumour area. These new vessels leaked ICG dye profusely, but were less demonstrable with fluorescein angiography. These choroidal neovascular malformations were different in location and morphology from the intratumoral vascularisation observed in untreated melanoma. Furthermore echography did not show any evidence of tumour recurrence. The choroidal new vessels when observed over a period of 12-18 months increased in size in the absence of echographic tumour recurrence.
DISCUSSION
Histological findings in the choroid from eyes treated with radiotherapy for choroid melanomas are similar irrespective of the source of radiation.8 These changes include sclerosis of choroidal vessels, atrophy of the different layers of the choroid and Bruch's membrane, and proliferation of the RPE.14 FF A has also been used simultaneously to assess the chorioretina for complications of radiotherapy, and follow-up of tumour regression/involutio n. 5,15 -17 The reported changes in the choroid were choroidal telangiectasisl5,16 and progressive vascular closure, but the smaller choroidal vessels were visible only where the RPE atrophy and partial/total loss of the choriocapillaries were sufficiently advanced. 5 In this study, ICG-A highlighted the choroidal circulation even where the RPE atrophic changes were not present or advanced enough to allow adequate view of the choroidal vasculature with FF A. The angiograms demonstrated that morpholo gically the features of radiation choroidal vasculo pathy -beading or irregular calibre variation, telangiectatic-like dilatations, micro aneurysms and new vessel formation -were similar to those previously described in the retina. This ICG-A study further confirmed that vascular closure occurred in the peri tumoral normal choroid within 3-4 months of brachytherapy. The vaso-occlusion 743 seemed to occur in the smaller vessels initially and slowly progressed to involve the larger vessels, i.e. the rate and degree of choroidal vascular closure seemed to be inversely related to the size of· the vessels. Similar patterns have been noted in retinal vascular response to radiation injury.I8 -20 These findings are consistent with those of HayrehI5 and McFaul and Bedford,16 who also showed telangiec tasis of the residual choroidal vessels in radiation choroidopathy following brachytherapy for choroidal melanoma.
Vascular wall staining was demonstrable only in the larger choroidal vessels and was observed in the late post-radiation period. Some of the vessels which stained subsequently became non-perfused in the longer term after radiotherapy. Furthermore, stain ing of vascular walls observed angiographically (with FFA in previous studies and ICG-A in this study) always seemed to be associated with occlusion of the adjoining vessels or the particular vessels at a later date. Vascular wall staining, however, did not necessarily precede all vascular occlusions.
It has been suggested by some authorsl7,21 that inflammation of the choroid occurs in the early post irradiation period and that this inflammation leads to fluorescein dye leak into the vitreous in the early post-treatment period, and staining of individual vascular walls later.9 However, despite histopatholo gical demonstrations of early choroidal oedema and subsequent atrophy and occlusion of choroidal vasculature (in experimental and clinical studies) no evidence of a true vasculitis has ever been demon strated in any of these studies.5,9-I7 It is suggested that choroidal vascular wall staining with ICG in radiation choroidopathy is due to radiation-induced endothelial cell loss and/or dys function rather than a true vasculitis. Progression leads to vascular occlusion. This thesis is consistent with previous observation of platelet aggregates in the choriocapillaries in experimental studies of radiation choroidopathy?2
Of particular interest was the observation of choroidal neovascularisation in the irradiated zone outside the original tumour area. These new vessels were more distinctly visualised with ICGA than on FF A. The choroidal new vessels observed in our patient were not thought to represent tumour recurrence since funduscopy and echography demon strated a flat scar, and there was no evidence of tumour regrowth. Furthermore, the new vessels were located outside the original tumour area, and the ICGA morphology of these vessels was different from that observed in untreated or inadequately treated melanomas.
Choroidal neovascularisation is occasionally asso ciated with untreated choroidal melanomas23 and has also been reported after successful treatment of choroidal melanomas with photocoagulation24•25 and following brachytherapy for retinoblastoma,z6 To our knowledge there are no previous reports in the literature of choroidal neovascularisation associated with irradiated melanoma. The pathophysiological mechanisms responsible fot the choroidal neovascu larisation following radiation injury are possibly related to those that occur in the retina, as well as to the disorganisation of the outer retina and Bruch's membrane produced by the very high doses of ionising radiation. However, since sizeable choroidal melanomas have pronounced effects on the involved and surrounding retinal and choroidal vasculature, it may be inaccurate to attribute the neovascularisation to the effects of ionising radiation alone.
The presumed choroido-choroidal vascular chan nels filled rapidly from the choroidal circulation and remained competent, whereas the choroidal new vessels leaked dye. These channels represent a component of the healing process similar to the chorioretinal vascular anastomoses described within chorioretinal scars.27 Alternatively, they may repre sent dilatation of pre-existing vascular channels following occlusion of the more distal choroidal arteriolar circulation.
We postulate that the mechanism of radiation vasculopathy in the choroid is similar to that in the retina. The initiating event is localised endothelial cell loss which precipitates a cascade of events producing vascular occlusions,z°·22
